The company, represented by Executive Director R.T. Akhmetov, presented a report on our urology products and the development of a new product in collaboration with the National Center of Urology under the R&D program "System for Delivering Fluid into the Urinary Tract During Endourological Surgeries."
Representatives of medical institutions, particularly urologists, chief physicians, and the medical community of the republic, are familiarizing themselves with the products. Excellent feedback has been received, and there has been great interest in ordering through the Single Distributor, SKF LLC.

A pharmaceutical cluster is being created in Almaty. LS has learned the details.
According to the city administration, a 26-hectare site has been reserved within the "Innovative Technologies Park" special economic zone for the development of pharmaceuticals, medical device manufacturing, and technical production. Three projects are currently under development.
"They are being implemented by companies such as JULDYZ KENAN Co. LT, KYZAI, and A-Medical (Aksel i A) for 4.7 billion tenge, creating approximately 150 jobs," the government agency reported.
These companies plan to produce personal protective equipment (PPE), including masks, gowns, and gloves. They will also establish production of medical devices and equipment, including test kits, analyzers, and laboratory equipment.
Negotiations are currently underway with the Turkish pharmaceutical company ATABAY. A plant for the production of generic drugs and active pharmaceutical ingredients is expected to be built in the city. The Akimat added that future planned projects in the pharmaceutical and medical industries could collaborate with the Institute of Nuclear Physics on radiation sterilization and the application of nuclear technologies.
"The reactor (the WWR-K research nuclear reactor) is used for fundamental nuclear physics and materials science research, in-reactor testing, the production of radioisotopes for medicine and industry, gamma sources, neutron doping of silicon, and neutron activation analysis," the Akimat concluded.

In October 2020, it was reported that the pharmaceutical cluster would be created in the Almaty industrial zone. However, in November of that year, it was announced that it would be located in the PIT SEZ. Two plants were planned to be built there between 2021 and 2023. Investments were expected to amount to 6.8 billion tenge. As a reminder, a plant producing four types of test systems—rapid tests, PCR tests, ELISA tests, and Petri dishes—opened in Almaty this year. The facility will have a production capacity of 1.83 million tests per year. The cost is 4.6 billion tenge.
Background
The PIT SEZ is located in the Alatau microdistrict of the Medeu district and borders the Institute of Nuclear Physics.
ATABAY produces over 100 types of pharmaceuticals, agricultural and veterinary chemicals, including antibiotics, antihistamines, anticancer drugs, antituberculosis medications, and other drugs.

Yesterday, the groundbreaking ceremony for a new plant for the production of disposable medical devices took place in the Innovative Technologies Park special economic zone.
The investment project is being implemented by the manufacturing company Juldyz Kenan Co., LTD, with the support of the city's Entrepreneurship and Investment Department, the European Bank for Reconstruction and Development, and Jýsan Bank.

The construction of the plant, which will create approximately 100 jobs, will involve 1.5 billion tenge in private investment, plus a similar amount for the acquisition of high-tech equipment. Completion is scheduled for June 2024.

As Ruslan Akhmetov, the company's Commercial Director, noted, over the 30 years of its existence, Juldyz Kenan has made significant progress in developing the domestic medical cluster.

"We are a leading manufacturer of medical devices, producing approximately three million units annually. Today, we are launching construction of our second plant for the production of disposable sterile medical devices. Its commissioning will increase the volume of finished products to 10 million per year." "This means we can meet virtually the entire demand of the Kazakhstani market," said Ruslan Akhmetov.

The company's product range is wide: from catheters and probes to containers for collecting pathological material, and much more, all meeting international standards. Leading medical professionals from the institutes of surgery, obstetrics and gynecology, and urology participate in their development.

"Our mission is to make high-quality healthcare accessible to all Kazakhstanis, at par with world standards. Every year, foreign specialists audit all production cycles at our company. Our portfolio currently includes 151 types of products, which we supply throughout the country," noted the company representative.

The production area covers 5,600 square meters, with over 1,000 square meters allocated for auxiliary spaces. According to the design, the production facilities will include "clean zones"—bacterial-free and completely sterile. The building is also designed to be highly resistant to seismic vibrations.

Today, the company sells its products not only domestically but also exports to Uzbekistan and Kyrgyzstan. Baglan Bakkulova, founder of Juldyz Kenan Co., LTD, admits that profits from medical device production are meager. The market price for catheters, for example, does not exceed 250 tenge.

"Our current production facility covers over 1,000 square meters. During the pandemic, when the country faced a shortage of medical devices, we decided to expand our production capacity. Market demand is very high today, as the entire world is working with disposable products to prevent hospital-acquired infections. Disposable medical devices reduce hospital stays and labor costs," commented Baglan Bakkulova.

The article was published in issue No. 121 of the Vecherniy Almaty newspaper on October 12, 2023, under the title "Medical Cluster – to a New Level."

On October 11, a groundbreaking ceremony was held for a new medical device manufacturing plant (catheters, probes, containers for collecting pathological specimens, and much more) in the Park of Innovative Technologies special economic zone in the Alatau microdistrict.

1.5 billion tenge of private investment will be invested in the plant's construction, which will create approximately 100 jobs. The planned completion date is June 2024.
Land plots for investment projects within the Alatau SEZ are provided on a free-of-charge sublease basis. The land plots are equipped with the necessary infrastructure, are distributed among clusters, and comply with all sanitary standards.

We began actively developing the medical field at the Park of Innovative Technologies Alatau SEZ in 2020, when the entire world was faced with a global pandemic. "Therefore, the production of medical equipment, medical devices, and pharmaceuticals was also included in the special economic zone's priority activities, and a 25-hectare site was allocated. A number of projects are currently being implemented in this area. In addition to the medical sector, the PIT SEZ is also implementing projects in instrument making, information technology, data centers, electrical equipment, and other fields. Currently, we are implementing more than 10 projects totaling over 20 billion tenge," said Olzhas Sartayev, CEO of the PIT SEZ management company, Alatau Technopark LLP.
The plant's production capacity will be 10 million units per year. The domestic manufacturer plans to sell its products not only domestically but also export them to Uzbekistan and Kyrgyzstan.
"This year, our company turns 30 years old. My husband, Kenes Kusainov, founded it; he is an anesthesiologist by profession. At that time, the market was in dire need of disposable medical products, which is where this idea came from. We started with three product lines and have now expanded our range to 110. We currently supply our highly sought-after products to all healthcare facilities, with volumes of 3.5-4 million units. We currently have our own production facility in Almaty, covering over 1,000 square meters. We not only manufacture but also develop new products at the request of healthcare professionals. We have our own design bureau and technologists," said Baglan Bakkulova, Director of JULDYZ KENAN Co., LTD.
The investment project is being implemented with the support of the Almaty Department of Entrepreneurship and Investment. The investment project is being supported by the Almaty Business Development Company. "We assisted this project in obtaining SEZ residency status and technical specifications. We are currently discussing the possibility of providing preferential financing under the regional Almaty Business program. We are working with government agencies and will continue to provide support through a one-stop shop," noted Aidan Ramazan, Chairman of the Board of Almaty Business Development Company.
Almaty is actively working to attract investors, particularly in three priority areas: the development of high-tech manufacturing, tourism, and creative industries. Under state and regional programs, small and medium-sized businesses in the manufacturing industry are eligible for preferential financing of up to 500 million tenge.

In 2025, the Almaty free economic zone "Information Technology Park" plans to launch seven projects, creating 450 jobs. A press release issued by the city's Department of Entrepreneurship and Investment on May 12 listed some of the projects: Kaspi Cloud, MedProPharm, Juldyz Kenan Ltd., A-Medical, and others.

A total of 12 projects are under construction within the "PIT" SEZ, eight of which are in the medical and pharmaceutical industries, according to the Akimat's press service.
In 2024, the SEZ created 6,760 jobs and produced goods worth 218.1 billion tenge. Two factories opened—Malaysia's OISB Kazakhstan and Smart Alatau.

OISB Kazakhstan is a plant manufacturing electrical equipment and power distribution systems. The project cost is estimated at 980 million tenge. Production capacity is 2,000 units per year. The investment project is being implemented by the Central Asian office of Offshore Industries Sdn. Bhd. (OISB), a Malaysian company operating in the oil, gas, and electrical products markets since 1976.
Smart Alatau is a manufacturer of electronics and telecommunications equipment, including Ethernet switches, service routers, home routers, and more. It supplies products to Kyrgyzstan, Uzbekistan, Azerbaijan, and other countries.
The PIT SEZ occupies 163 hectares in the Alatau microdistrict. Participants in the PIT SEZ are offered various preferences and benefits, reducing their tax and customs burdens. Currently, 182 companies operate in the zone, creating 6,971 jobs.

In 2025, 70 billion tenge has been allocated for business development in Almaty, 52.8 billion of which will come from the local budget, according to the city administration's press service.

As of March 1, the following funds were supported:

• 197 projects—18.8 billion tenge in loans,
• 135 projects—16.6 billion tenge through the Unified Program,
• 30 billion tenge in subsidies,
• 1.6 billion tenge in guarantees,
• 200 million tenge in grants (competition until the end of 2025).

The total investment volume amounted to 2.1 billion tenge, Vecher.kz reports.

• A new high-tech medical device manufacturing plant opened in the Special Economic Zone "Innovative Technologies Park" in Almaty.

Juldyz Kenan Co., Ltd. is the only manufacturer of catheters, probes, containers for collecting pathological material, and other medical devices in the country. Total investment amounted to 2.1 billion tenge. The company has created approximately 100 jobs, and its production capacity allows for an annual output of up to 10 million units. The plant's products are in demand in various medical fields, from intensive care and surgery to neonatology and pediatrics. The entire product line is certified and meets international quality standards ISO 13485.

The company covers the entire production cycle: from design and clinical testing to packaging and sterilization. Its 7,000 square meter facility houses modern production lines, a laboratory, and warehouse space. Manufacturing processes include extrusion, injection molding, milling, assembly, packaging, and sterilization in a Class H14 cleanroom environment.

According to investor and plant director Baglan Bakkulova, Juldyz Kenan has been operating in the market for over 30 years and currently offers 169 products. With the opening of the new facility, the company will be able to meet up to 90% of domestic market demand. Currently, the company's products are supplied to more than 2,670 medical institutions. Exports are also conducted to Russia, Uzbekistan, Kyrgyzstan, Tajikistan, Belarus, Iran, and Afghanistan.

The company places particular emphasis on innovation. Specifically, it has completed the registration of needle-free systems, which it plans to launch in the market in volumes of up to 3-4 million units per year. Production is carried out using high-quality, safe raw materials, including components from the United States.
During the opening ceremony, Zauresh Amanzholova, MD, Chair of the Board of Directors of the Scientific Center for Obstetrics, Gynecology, and Perinatology, emphasized that the plant's products are already being used in obstetrics. Specifically, the company has launched the production of clamps for newborns, which were previously unavailable on the domestic market.

The opening of the plant marked a significant step in the development of domestic industry and medical infrastructure, as well as strengthening Kazakhstan's export potential for medical devices. As a reminder, 182 companies are currently members of the Park of Innovative Technologies SEZ, where the plant is located. Investments have totaled 205 billion tenge, and more than 6,900 jobs have been created. Six new projects worth 18.5 billion tenge (including Juldyz Kenan Ltd.) are planned for launch in 2025.

A new high-tech medical device manufacturing plant opened in Almaty within the Park of Innovative Technologies Special Economic Zone, Bizmedia.kz reports.

A new high-tech medical device manufacturing plant belonging to Juldyz Kenan Co., Ltd. opened in Almaty's Park of Innovative Technologies.
The opening of the plant marks a significant step in the development of the domestic industry and medical infrastructure, as well as strengthening Kazakhstan's export potential in the medical device sector.
According to Baglan Bakkulova, investor and plant manager, Juldyz Kenan has been operating in the market for over 30 years and currently offers over 169 products. With the opening of the plant, the company will be able to meet up to 90% of domestic market demand. The company's products are currently shipped to more than 2,670 medical organizations across the country. Products are also exported to Russia, Belarus, and Central Asian countries.

About Production
Juldyz Kenan Co., Ltd. is the only manufacturer of medical products such as catheters, probes, and containers for collecting pathological specimens in the country.
The total investment in the plant amounted to 2.1 billion tenge. The company has created over 100 jobs. Production capacity will allow for the annual production of up to 10 million units of products, which are in demand in medical fields ranging from intensive care and surgery to neonatology and pediatrics. The entire product line is certified and complies with international quality standards ISO 13485.

The company covers the entire production cycle: from design and clinical testing to packaging and sterilization. The plant occupies an area of ​​7,000 square meters, housing modern production lines, a laboratory, and warehouse space. Production processes include extrusion, injection molding, milling, assembly, packaging, and sterilization in H14 cleanroom conditions.

Innovation
The company places special emphasis on innovation. Registration of needle-free systems is currently being finalized, with plans to launch them in a market volume of 3-4 million units per year. Production will be carried out using high-quality, safe raw materials.
Zauresh Amanzholova, Chair of the Board of Directors of the Scientific Center for Obstetrics, Gynecology, and Perinatology, announced at the opening ceremony that the company has launched the production of clamps for newborns, previously unavailable on the domestic market, and the plant's products are already being used in obstetrics.

What else
Today, 182 companies are participants in the "Park of Innovative Technologies" SEZ, the volume of investment attracted amounts to 205 billion tenge, and more than 6,900 jobs have been created. Six new projects worth 18.5 billion tenge are planned for launch in 2025.

The development of high-tech manufacturing is key to sustainable economic growth and the country's industrial independence.
One example of a successful domestic enterprise making a significant contribution to the economy of Kazakhstan and the city of Almaty is JuldyzKenan Co., Ltd. Currently, the company is a leading manufacturer of medical devices, located in the Special Economic Zone "Park of Innovative Technologies."
With over 30 years of history, the company has become the country's only manufacturer of catheters, probes, containers for collecting biomaterial, and other critical medical products. Today, the company's products are in demand by more than 2,670 medical organizations and are also exported to Russia, Uzbekistan, Kyrgyzstan, Tajikistan, Belarus, Iran, and Afghanistan, strengthening Kazakhstan's export potential.
A significant milestone in the company's development was the opening of a new high-tech plant on June 5 in Almaty. Total investment amounted to 2.1 billion tenge, approximately 100 new jobs were created, and production capacity allows for the annual production of up to 10 million units.

This not only significantly expanded the city's industrial base but also enabled the company to meet up to 90% of the domestic market's needs, directly reducing the country's dependence on imported medical products.

This result was achieved largely thanks to government support provided through the "Business Roadmap 2025" program and the "Damu-Ondіris" preferential lending program.
Subsidies and guarantees from banks allowed the company to invest in the acquisition of modern equipment, expansion of production facilities, and replenishment of working capital. As a result, productivity increased, new product lines were launched, and the debt burden was reduced: the interest rate on one loan was reduced from 14% to 8%, and on another, to 6%.
Production is carried out fully, from design to packaging and sterilization, in compliance with international standards. Cutting-edge technologies are used. The plant's products are in demand in various medical fields, from intensive care and surgery to neonatology and pediatrics.

In addition to meeting domestic market needs, Juldyz Kenan Co., Ltd. is actively developing innovative solutions. Specifically, a needle-free system has been registered and is being prepared for mass production, with a production capacity of up to 4 million units per year. Production is carried out using high-quality, safe raw materials, including components from the United States. This will not only provide safer and more effective solutions for Kazakhstani healthcare but also strengthen the country's position in the international medical equipment market. Thus, Juldyz Kenan Co., Ltd. is making a significant contribution to the development of Almaty's industrial potential, creating jobs, strengthening its production base, and stimulating exports. At the same time, the company is an example of successful collaboration between business and government.